Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05862727 · ClinicalTrials.gov registry record · NA

Preschool Attention and Sleep Support (PASS)

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
46
Enrollment target

NCT05862727: Completed NA study, sponsored by Duke University.

NCT05862727 is a NA study that has completed, run by Duke University. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05862727, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target

Study Summary

This study will be investigating two telehealth interventions for preschoolers with ADHD. The study is divided into two Aims. During Aim 1, caregivers of preschoolers with attention concerns, pediatric behavioral health professionals, and pediatric primary care providers will take part in two virtual focus groups to provide their perspective on ways to improve the telehealth intervention being evaluated.

Primary Outcome

A clinician-rated, 18-item assessment with a 4-point Likert scale ranging from Rarely or never to Very Often. Lower scores indicate better outcomes.

Interventions

  • BEHAVIORAL Telehealth Intervention

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2023-07-24
Est. Completion 2026-01-30
Phase NA
Duke University

1,725 total trials

What the finished NCT05862727 record still lists

NCT05862727 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Telehealth Intervention is the first listed.

NCT05862727 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05862727 about?

NCT05862727 is a clinical study titled "Preschool Attention and Sleep Support (PASS)". This study will be investigating two telehealth interventions for preschoolers with ADHD. The study is divided into two Aims. During Aim 1, caregivers of preschoolers with attention concerns, pediatric behavioral health professionals, and pediatric primary care providers will take part in two virtua...

What is the current status of trial NCT05862727?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2023-07-24. Estimated completion is 2026-01-30.

What interventions are being tested in trial NCT05862727?

The interventions under investigation include: Telehealth Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05862727?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05862727's enrollment target sits among peer trials

46 1402nd of 2000 higher than 590 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05862727, the US trial registry maintained by the National Library of Medicine. NCT05862727 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.